TEVA PHARMACEUTICAL INDUSTRIES LIMITED Employee Count
No Employee Count for TEVA on this site yet.
- 2025-12-31: Xbrl:LongTermPurchaseCommitmentByCategoryOfItemPurchased ResearchAndDevelopmentArrangement: 200; Xbrl:TaxCreditCarryforward PreferredTechnologicalEnterprises: 200; Filing 2026-02-03.
- 2024-12-31: Xbrl:LongTermPurchaseCommitmentByCategoryOfItemPurchased ResearchAndDevelopmentArrangement: 200; Xbrl:TaxCreditCarryforward PreferredTechnologicalEnterprises: 200; Filing 2025-02-05.
- 2023-12-31: Xbrl:LongTermPurchaseCommitmentByCategoryOfItemPurchased ResearchAndDevelopmentArrangement: 200; Xbrl:TaxCreditCarryforward PreferredTechnologicalEnterprises: 200; Filing 2024-02-12.
- 2022-12-31: Xbrl:LongTermPurchaseCommitmentByCategoryOfItemPurchased ResearchAndDevelopmentArrangement: 200; Xbrl:TaxCreditCarryforward PreferredTechnologicalEnterprises: 200; Filing 2023-02-10.
Source checked: the stored Employee page for TEVA and the employee counts in its SEC EDGAR filings (CIK 818686).
Headcount breakdown as filed
| Fiscal year end | Employees | Xbrl:LongTermPurchaseCommitmentByCategoryOfItemPurchased | Xbrl:TaxCreditCarryforward | Filing |
|---|---|---|---|---|
| 2025-12-31 | ResearchAndDevelopmentArrangement: 200 | PreferredTechnologicalEnterprises: 200 | 2026-02-03 “” | |
| 2024-12-31 | ResearchAndDevelopmentArrangement: 200 | PreferredTechnologicalEnterprises: 200 | 2025-02-05 “” | |
| 2023-12-31 | ResearchAndDevelopmentArrangement: 200 | PreferredTechnologicalEnterprises: 200 | 2024-02-12 “” | |
| 2022-12-31 | ResearchAndDevelopmentArrangement: 200 | PreferredTechnologicalEnterprises: 200 | 2023-02-10 “” | |
| 2021-12-31 | ResearchAndDevelopmentArrangement: 20 | PreferredTechnologicalEnterprises: 20 | 2022-02-09 “” | |
| 2020-12-31 | ResearchAndDevelopmentArrangement: 200 | PreferredTechnologicalEnterprises: 200 | 2021-02-10 “” | |
| 2019-12-31 | ResearchAndDevelopmentArrangement: 200 | PreferredTechnologicalEnterprises: 200 | 2020-02-21 “” |